Cytek Biosciences, Inc. CTKB Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s accrued liabilities, current?
- Cytek Biosciences, Inc. (CTKB) reported accrued liabilities, current of $19.78M in Q1 2026.
- How has Cytek Biosciences, Inc.'s accrued liabilities, current changed year-over-year?
- Cytek Biosciences, Inc.'s accrued liabilities, current increased by 3.0% year-over-year, from $19.2M to $19.78M.
- What is the long-term trend for Cytek Biosciences, Inc.'s accrued liabilities, current?
- Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s accrued liabilities, current has grown at a 20.9% compound annual growth rate (CAGR), from $9.05M to $23.42M.